Terms: = Colorectal cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Staging
4 results:
1. A study of the immune infiltrate and patient outcomes in esophageal cancer.
Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
[TBL] [Abstract] [Full Text] [Related]
2. Effect of activated carbon nanoparticles on lymph node harvest in patients with colorectal cancer.
Tang L; Sun L; Zhao P; Kong D
Colorectal Dis; 2019 Apr; 21(4):427-431. PubMed ID: 30580490
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Schwartz enhanced visualization solution on staging colorectal cancer and clinicopathological features associated with lymph node count.
Chapman B; Paquette C; Tooke C; Schwartz M; Osler T; Weaver D; Wilcox R; Hyman N
Dis Colon Rectum; 2013 Sep; 56(9):1028-35. PubMed ID: 23929011
[TBL] [Abstract] [Full Text] [Related]
4. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial.
Ballonoff A; Kavanagh B; McCarter M; Kane M; Pearlman N; Nash R; Shah RJ; Raben D; Schefter TE
Am J Clin Oncol; 2008 Jun; 31(3):264-70. PubMed ID: 18525306
[TBL] [Abstract] [Full Text] [Related]
